IRD
Opus Genetics to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
Wednesday, September 3, 2025 BiopharmaWatch Research 1 min read Key Takeaway: Opus Genetics to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
Price reaction · baseline $1.23 (2025-09-02 close) · hit after-hours · 1 other IRD headline(s) in the window, move may be shared
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+140%
120-day peak, hindsight
Typical move
6.3%
average across 11 past catalysts
Cash runway
~22 mo
Low dilution risk
Lead asset
APX3330
Phase 2 · Diabetic Retinopathy
Full Press Release Details
Opus Genetics to Participate in the H.C. Wainwright 27th Annual Global Investment Conference.